190 related articles for article (PubMed ID: 23153988)
1. Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for the detection of skeletal muscle and skin metastases in uterine leiomyosarcoma: a case report.
Ozdemir E; Poyraz NY; Uzun B; Türkölmez S
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):257-9. PubMed ID: 23153988
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas.
Kao YH; Saad U; Tan AE; Magsombol BM; Padhy AK
Acta Radiol; 2011 May; 52(4):463-6. PubMed ID: 21498277
[TBL] [Abstract][Full Text] [Related]
3. Multiple leiomyosarcoma foci in 18F-FDG PET-CT.
Sürücü E; Aslan M; Karahan P; Durak H
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):269-70. PubMed ID: 23122743
[No Abstract] [Full Text] [Related]
4. Fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging of uterine leiomyosarcomas: 2 cases report.
Zhang HJ; Zhan FH; Li YJ; Sun HR; Bai RJ; Gao S
Chin Med J (Engl); 2011 Jul; 124(14):2237-40. PubMed ID: 21933635
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous and intramuscular metastases of cervix cancer detected with ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography after the chemoradiation therapy.
Tamam MO; Mulazimoglu M; Aydin T
Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):128-9. PubMed ID: 23177331
[No Abstract] [Full Text] [Related]
6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
7. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
[TBL] [Abstract][Full Text] [Related]
8. The value of 18-FDG PET/CT imaging in a patient with atypical metastatic colorectal cancer--case report: 18-FDG PET/CT in colorectal cancer.
Hlavatá Z; Pazderová N; Povinec P; Paulíny P; Majidi A; Fiala P; Martanovic P; Sálek T
Klin Onkol; 2009; 22(6):284-7. PubMed ID: 20099747
[TBL] [Abstract][Full Text] [Related]
9. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular metastasis of uterine cervix cancer on F-18 FDG PET/CT.
Hong IK; Kim DY
Clin Nucl Med; 2011 Jun; 36(6):e39-41. PubMed ID: 21552014
[TBL] [Abstract][Full Text] [Related]
11. PET-CT demonstration of extensive muscle metastases from breast cancer.
Liu Y; Ghesani N; Mirani N; Zuckier LS
Clin Nucl Med; 2006 May; 31(5):266-8. PubMed ID: 16622333
[No Abstract] [Full Text] [Related]
12. Schwannomatosis/neurofibromatosis type 2 associated multiple schwannomas visualized on FDG-PET/CT.
Beylergil V; Haque S; Carver A; Bilsky MH; Carrasquillo JA
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):275-6. PubMed ID: 23582492
[No Abstract] [Full Text] [Related]
13. Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT.
Juan YH; Saboo SS; Tirumani SH; Khandelwal A; Shinagare AB; Ramaiya N; Krajewski KM
AJR Am J Roentgenol; 2014 May; 202(5):W422-38. PubMed ID: 24758677
[TBL] [Abstract][Full Text] [Related]
14. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.
Wehrli NE; Bural G; Houseni M; Alkhawaldeh K; Alavi A; Torigian DA
Semin Nucl Med; 2007 May; 37(3):195-205. PubMed ID: 17418152
[TBL] [Abstract][Full Text] [Related]
15. Isolated facial muscle metastasis from renal cell carcinoma on F-18 FDG PET/CT.
Kang S; Song BI; Lee HJ; Jeong SY; Seo JH; Lee SW; Ahn BC; Lee J; Lee HJ
Clin Nucl Med; 2010 Apr; 35(4):263-4. PubMed ID: 20305417
[No Abstract] [Full Text] [Related]
16. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
17. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
Graafland NM; Leijte JA; Valdés Olmos RA; Hoefnagel CA; Teertstra HJ; Horenblas S
Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581
[TBL] [Abstract][Full Text] [Related]
18. Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.
Gaeta CM; Vercher-Conejero JL; Sher AC; Kohan A; Rubbert C; Avril N
Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):352-66. PubMed ID: 24322792
[TBL] [Abstract][Full Text] [Related]
19. Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
Niebling MG; Bastiaannet E; Hoekstra OS; Bonenkamp JJ; Koelemij R; Hoekstra HJ
Ann Surg Oncol; 2013 Sep; 20(9):3098-105. PubMed ID: 23612885
[TBL] [Abstract][Full Text] [Related]
20. Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors.
Bischoff M; Bischoff G; Buck A; von Baer A; Pauls S; Scheffold F; Schultheiss M; Gebhard F; Reske SN
Arch Orthop Trauma Surg; 2010 Jul; 130(7):819-27. PubMed ID: 19636577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
